Literature DB >> 27245848

The effect on pregnancy and multiples of transferring 1-3 embryos in women at least 40 years old.

Nouf M Alasmari1, Weon-Young Son1, Michael H Dahan2.   

Abstract

UNLABELLED: PURPOSE "CAPSULE" IS MANDATORY. PLEASE PROVIDE.SINGLE EMRBYO TRANSFER (SET) IN WOMEN ≥40 YEARS OLD APPEARS TO LOWER THE CHANCE OF A PREGNANCY. HOWEVER, IT MINIMIZES THE RISK OF MULTIPLE PREGNANCIES EVEN IN WOMEN OF ADVANCED MATERNAL AGE. THEREFORE, WOMEN 40 YEARS OF AGE OR OLDER SHOULD BE OFFERED (SET).: This study was performed to investigate the multiple pregnancies and live birth rates when 1-3 embryos are transferred at this age in women at least 40 years of age.
METHOD: A retrospective analysis of data which included 631 women aged 40 to 46 years, who underwent 901 cycles of IVF, from August 2010 to June 2012 was undertaken. These women underwent embryo transfer of 1-3 non-donor fresh embryo(s).
RESULTS: Results suggested that the average pregnancy rate when up to three embryos were transferred was 25 % for women 40 years old, 20 % for women 41 years old, 16 % for women 42 years old, 17 % for women 43 years old, 8 % for women 44 years old, 6 % for women 45 years old, and 0 % for women 46 years old. No live births occurred in women treated after their 44th birthday, and only patients younger than 42 years of age receiving double embryo transfer had a live birth of twins. Live birth rates increased as more embryos were transferred for 40- and 42-year-old subjects (p = 0.01 and 0.05, respectively).
CONCLUSIONS: From these results, it was concluded that SET in women ≥40 years old appears to lower the chance of a pregnancy. However, it minimizes the risk of multiple pregnancies even in women of advanced maternal age. Women 40 years of age or older should be offered single-embryo transfer. Further studies are needed to determine risk of multiple pregnancies in women 42 years of age or older when few embryos are transferred. Decisions on the number of embryos to transfer should be on a case by case basis, in discussion with the patient.

Entities:  

Keywords:  Advanced maternal age; Assisted reproductive technology; Elective single-embryo transfer; Multiple pregnancy rates

Mesh:

Year:  2016        PMID: 27245848      PMCID: PMC5010807          DOI: 10.1007/s10815-016-0749-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  30 in total

1.  Pregnancy-related mortality from preeclampsia and eclampsia.

Authors:  A P MacKay; C J Berg; H K Atrash
Journal:  Obstet Gynecol       Date:  2001-04       Impact factor: 7.661

2.  In-vitro fertilisation in women aged 40 years and above.

Authors:  S W Seng; C T Yeong; S F Loh; N Sadhana; S K E Loh
Journal:  Singapore Med J       Date:  2005-03       Impact factor: 1.858

3.  Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.

Authors:  A Tsafrir; A Simon; A Revel; B Reubinoff; A Lewin; N Laufer
Journal:  Reprod Biomed Online       Date:  2007-03       Impact factor: 3.828

4.  Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization.

Authors:  Ann Thurin; Jon Hausken; Torbjörn Hillensjö; Barbara Jablonowska; Anja Pinborg; Annika Strandell; Christina Bergh
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

5.  Pregnancies from single normal embryo transfer in women older than 40 years.

Authors:  Michael Obasaju; Arjun Kadam; Teresa Biancardi; Khalid Sultan; Majid Fateh; Santiago Munné
Journal:  Reprod Biomed Online       Date:  2001       Impact factor: 3.828

6.  Assisted reproduction in women over 40 years of age: how old is too old?

Authors:  Ariel Hourvitz; Ronit Machtinger; Ettie Maman; Micha Baum; Jehoshua Dor; Jacob Levron
Journal:  Reprod Biomed Online       Date:  2009-10       Impact factor: 3.828

7.  A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization.

Authors:  D K Gardner; W B Schoolcraft; L Wagley; T Schlenker; J Stevens; J Hesla
Journal:  Hum Reprod       Date:  1998-12       Impact factor: 6.918

8.  Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.

Authors:  S L Tan; N Maconochie; P Doyle; S Campbell; A Balen; J Bekir; P Brinsden; R G Edwards; H S Jacobs
Journal:  Am J Obstet Gynecol       Date:  1994-08       Impact factor: 8.661

9.  Factors affecting success rates in two concurrent clinical IVF trials: an examination of potential explanations for the difference in pregnancy rates between the United States and Europe.

Authors:  Valerie L Baker; Clarence E Jones; Barbara Cometti; Fred Hoehler; Bruno Salle; János Urbancsek; Michael R Soules
Journal:  Fertil Steril       Date:  2009-10-07       Impact factor: 7.329

10.  Chromosome abnormalities in 1255 cleavage-stage human embryos.

Authors:  C Márquez; M Sandalinas; M Bahçe; M Alikani; S Munné
Journal:  Reprod Biomed Online       Date:  2000       Impact factor: 3.828

View more
  1 in total

1.  Morphokinetic parameters as auxiliary criteria for selection of blastocysts cultivated in a time-lapse monitoring system.

Authors:  José Fernando de Macedo; Luiz Mauro Oliveira Gomes; Maristela Rodrigues Oliveira; Gustavo Capinzaiki Macedo; Giovanna Capinzaiki Macedo; Daniela Oliveira Gomes; Camila Dutra Souza Francisquini; Bruna Oliveira Ambrogi; Sandra Irene Sprogis Dos Santos
Journal:  JBRA Assist Reprod       Date:  2020-10-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.